Neuralstem IncAdd to My Watchlist

CUR:USNYSE MKT LLCIndustry: Medical-Biomedical/Gene
  • 4.01
    Last
  • 0.14  3.62%
    Today's Change
  • 3.87
    Previous Close
  • Today
     
    1.59
    4.81
    52 Week Low - High
8:04 pm ET 8/28/2014
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding87 million
Market Cap$348 million
Return on Equity ttm-159.35%
Last DividendCUR:US does not pay a dividend
Earnings
EPS: Year Actual ttm-0.286
EPS: Year Est. 12/14 ttm-0.220
 
EPS: Quarterly Actual 6/14 -0.08
EPS: Quarterly Est. 9/14 -0.06
 
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate-58.82
Company Description
Neuralstem Inc. provides medical research services. The Company develops and commercializes clinical treatment for central nervous system diseases. Neuralstem serves the medical field worldwide.
Revenue$110,000
Net Income$-20 million
Total Assets$19 million
Employees16
Web Sitewww.neuralstem.com

Latest Headlines

No news available.

    Watchlist

    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now

     

    Not Registered?

    Get complete access to The Washington Post online - it's FREE!